TITLE

Stem-cell agency faces budget dilemma

AUTHOR(S)
Check Hayden, Erika
PUB. DATE
February 2012
SOURCE
Nature;2/2/2012, Vol. 482 Issue 7383, p15
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on budget plans for the California Institute for Regenerative Medicine (CIRM) to address the end of its financial support from the state of California by 2021. Topics include the impact of budget shortfalls in California, the cancellation of its only embryonic stem cell clinical trial in 2011, and the uncertainty of federal stem cell funding after 2012. CIRM is looking to a non-profit model of private funding as well as focusing on the clinical applications of its research.
ACCESSION #
70982805

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics